MELISSA BLACK: Open Payments
NPI 1013538834 · EAST LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$538 in 25 payments from 15 companies in 2025. Trend: 2023 $90 · 2024 $0 · 2025 $538
Food & beverage: $538
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 3 | $94 |
| Neurocrine BioSciences, Inc. | 4 | $92 |
| Corium, LLC | 3 | $50 |
| Lundbeck LLC | 2 | $48 |
| Biogen, Inc. | 2 | $41 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Boston Scientific Corporation | 1 | $19 |
Products named: ARISTADA, INGREZZA, REXULTI, Azstarys, ZURZUVAE, FANAPT, Auvelity, AUSTEDO XR.
Industry payments across MI — which companies pay providers there.
